Tilray Receives First New Cannabis Cultivation License in Germany Under New Regulations
Tilray Brands, Inc., a global leader in cannabis research, cultivation, production, and distribution, today announced that its Germany
Browsing: Tilray
Despite Doubling, These Cannabis Stocks Are Bad News
These three pot stocks are soaring — unfortunately their rallies lack substance.
Leamington Loses 120 Jobs as Tilray Kills Cannabis Facility
After just a year of growing pot in Leamington, Tilray Inc., one of Canada’s biggest cannabis companies, is pulling up its local stakes and shutting down a greenhouse operation that employed about 120 workers.
Why Aurora Cannabis Stock Plunged Today
Multiple factors could weigh on marijuana sales and make it harder for Aurora to achieve near-term profitability.
Tilray Jumps on U.S. Study of Cannabis in Breast Cancer Patients
Tilray Inc. shares jumped as much as 14 per cent after announcing it successfully imported medical cannabis into the U.S.
Tilray Expands Retail Footprint by Buying Calgary Pot Shop Operator for $110 Million
Will use Four20’s expertise to help expand in other provinces.
Tilray® Announces Agreement to Export First Shipment of Medical Cannabis From Portugal to Germany
Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced it has entered into an agreement with Cannamedical Pharma GmbH (“Cannamedical”) through its wholly-owned subsidiary Tilray Portugal Unipessoal Lda.
6 Best Cannabis Stocks to Buy on U.S. Exchanges
These are 2019’s top pot stocks.
Tilray to Acquire Hemp Food Company Manitoba Harvest for Up to $419 Million
The market for hemp-derived CBD was estimated at US$591 million in 2018 and is expected to balloon to US$22 billion by 2022.
Shoppers Drug Mart Signs Marijuana Supply Deal with Tilray Canada
Shoppers Drug Mart has lined up a third cannabis supply agreement as part of its ambition to dispense the drug amid what experts say is increasing support among pharmacists to distribute medical pot and expectations that the regulatory framework needed will come to fruition.
